Nan–Yao Lee

5.3k total citations · 1 hit paper
151 papers, 3.9k citations indexed

About

Nan–Yao Lee is a scholar working on Infectious Diseases, Epidemiology and Molecular Medicine. According to data from OpenAlex, Nan–Yao Lee has authored 151 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Infectious Diseases, 63 papers in Epidemiology and 36 papers in Molecular Medicine. Recurrent topics in Nan–Yao Lee's work include Antibiotic Resistance in Bacteria (36 papers), Bacterial Identification and Susceptibility Testing (24 papers) and Antibiotics Pharmacokinetics and Efficacy (19 papers). Nan–Yao Lee is often cited by papers focused on Antibiotic Resistance in Bacteria (36 papers), Bacterial Identification and Susceptibility Testing (24 papers) and Antibiotics Pharmacokinetics and Efficacy (19 papers). Nan–Yao Lee collaborates with scholars based in Taiwan, United States and United Kingdom. Nan–Yao Lee's co-authors include Wen‐Chien Ko, Po‐Ren Hsueh, Chia‐Ming Chang, Po‐Lin Chen, Ching‐Chi Lee, Hsin–Chun Lee, Nai‐Ying Ko, Ming-Chi Li, Hsin‐Chun Lee and Chi‐Jung Wu and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Applied and Environmental Microbiology.

In The Last Decade

Nan–Yao Lee

147 papers receiving 3.8k citations

Hit Papers

Nanoparticles in the Treatment of Infections Caused by Mu... 2019 2026 2021 2023 2019 100 200 300

Peers

Nan–Yao Lee
Tara N. Palmore United States
Nan–Yao Lee
Citations per year, relative to Nan–Yao Lee Nan–Yao Lee (= 1×) peers Tara N. Palmore

Countries citing papers authored by Nan–Yao Lee

Since Specialization
Citations

This map shows the geographic impact of Nan–Yao Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nan–Yao Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nan–Yao Lee more than expected).

Fields of papers citing papers by Nan–Yao Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nan–Yao Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nan–Yao Lee. The network helps show where Nan–Yao Lee may publish in the future.

Co-authorship network of co-authors of Nan–Yao Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Nan–Yao Lee. A scholar is included among the top collaborators of Nan–Yao Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nan–Yao Lee. Nan–Yao Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Li, Chia‐Wen, et al.. (2025). Cardiometabolic multimorbidity in aging adults with HIV: Real-world evidence from a care cohort in Taiwan. Journal of Microbiology Immunology and Infection. 59(1). 21–27.
3.
Ko, Wen‐Chien, et al.. (2024). Efficacy of short- versus prolonged-courses of antimicrobial therapy for carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A propensity score-matched cohort study. Journal of Microbiology Immunology and Infection. 57(4). 594–600. 1 indexed citations
4.
Lee, Nan–Yao, Chien‐Ming Chao, Chi‐Chung Chen, et al.. (2023). Emergence and dissemination of multidrug-resistant Escherichia coli ST8346 coharboring blaNDM-5 and blaOXA-181 in Southern Taiwan, 2017–2021. Journal of Infection and Public Health. 16(10). 1675–1681. 4 indexed citations
5.
Lee, Jen‐Chieh, et al.. (2023). Clinical impact of the combination of rapid species identification and antifungal stewardship intervention in adults with candidemia. Journal of Microbiology Immunology and Infection. 56(6). 1253–1260. 4 indexed citations
6.
Tsai, Pei‐Shan, Nan–Yao Lee, Wen‐Yu Su, et al.. (2023). Antibody Profiling of Dengue Severities Using Flavivirus Protein Microarrays. Analytical Chemistry. 95(41). 15217–15226. 1 indexed citations
7.
Lai, Chung‐Hsu, Shang‐Yi Lin, Ching‐Chi Lee, et al.. (2023). In Vitro and In Vivo Antimicrobial Activities of Vancomycin and Rifampin against Elizabethkingia anophelis. International Journal of Molecular Sciences. 24(23). 17012–17012. 8 indexed citations
8.
Lee, Jen‐Chieh, et al.. (2022). Integration of antimicrobial stewardship intervention with rapid organism identification improve outcomes in adult patients with bloodstream infections. Journal of Microbiology Immunology and Infection. 56(1). 57–63. 6 indexed citations
9.
Hung, Jia‐Horung, Chaw‐Ning Lee, I‐Son Ng, et al.. (2021). Recent Advances in Photodynamic Therapy against Fungal Keratitis. Pharmaceutics. 13(12). 2011–2011. 26 indexed citations
10.
Tang, Hung-Jen, Yi‐Shan Tsai, Nan–Yao Lee, et al.. (2021). Risk of non-typhoidal Salmonella vascular infections is increased with degree of atherosclerosis and inflammation: A multicenter study in southern Taiwan. Journal of Microbiology Immunology and Infection. 55(3). 474–481. 7 indexed citations
11.
Ko, Wen‐Chien, et al.. (2021). Antimicrobial treatment of monomicrobial phenotypic carbapenem-resistant Klebsiella pneumoniae bacteremia: Two are better than one. Journal of Microbiology Immunology and Infection. 55(6). 1219–1228. 8 indexed citations
12.
Liu, Ping‐Yen, Yi‐Shan Tsai, Po‐Lin Chen, et al.. (2020). Application of an Artificial Intelligence Trilogy to Accelerate Processing of Suspected Patients With SARS-CoV-2 at a Smart Quarantine Station: Observational Study. Journal of Medical Internet Research. 22(10). e19878–e19878. 4 indexed citations
13.
Lee, Nan–Yao, et al.. (2020). Clinical impact of cefepime breakpoint in patients with carbapenem-resistant Klebsiella pneumoniae bacteraemia. International Journal of Antimicrobial Agents. 57(2). 106250–106250. 8 indexed citations
14.
Wang, Jiun‐Ling, Ching‐Chi Lee, Chung-Hsun Lee, et al.. (2018). Clinical Impact of Sequence Type 131 in Adults with Community-Onset Monomicrobial Escherichia Coli Bacteremia. Journal of Clinical Medicine. 7(12). 508–508. 7 indexed citations
15.
Tang, Hung-Jen, Yuan‐Pin Hung, Po‐Lin Chen, et al.. (2018). Bloodstream infections in hospitalized adults with dengue fever: Clinical characteristics and recommended empirical therapy. Journal of Microbiology Immunology and Infection. 52(2). 225–232. 16 indexed citations
16.
Tsai, Chin-Shiang, Yuan‐Pin Hung, Nan–Yao Lee, et al.. (2016). Community-onset Clostridium difficile infection at a tertiary medical center in southern Taiwan, 2007–2015. Journal of Microbiology Immunology and Infection. 51(2). 243–250. 11 indexed citations
17.
Lee, Ching‐Chi, Chia‐Wen Li, Ming-Chi Li, et al.. (2015). Fluoroquinolone therapy for bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Journal of Microbiology Immunology and Infection. 50(3). 355–361. 24 indexed citations
18.
Li, Chia‐Wen, et al.. (2015). Salmonella infective endocarditis. Journal of Microbiology Immunology and Infection. 49(3). 313–320. 29 indexed citations
19.
Cia, Cong-Tat, Mingji Li, Chia‐Wen Li, et al.. (2014). Community-onset bacteremia in kidney transplant recipients: The recipients fare well in terms of mortality and kidney injury. Journal of Microbiology Immunology and Infection. 49(5). 685–691. 10 indexed citations
20.
Chen, Po‐Lin, Pei-Jane Tsai, Chang‐Shi Chen, et al.. (2014). Aeromonas stool isolates from individuals with or without diarrhea in southern Taiwan: Predominance of Aeromonas veronii. Journal of Microbiology Immunology and Infection. 48(6). 618–624. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026